Press Releases 2008

   Display # 
1 Medicsight and Toshiba PACS division sign commercial agreement 13 Feb 09
2 Third Quarter Summary Trading Statement 2008 10 Dec 08
3 Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis 03 Dec 08
4 Medicsight to Present New Data at Major Radiology Conference 01 Dec 08
5 New Global Marketing Partnership with Ziosoft Unveiled at RSNA 2008 25 Nov 08
6 Notice of Annual General Meeting 20 Nov 08
7 Medicsight seeks FDA 510(k) clearance to market ColonCADTM in the US 18 Nov 08
8 American College of Radiology Imaging Network ("ACRIN") trial shows CT Colonography is now an option for colon cancer screening 23 Sep 08
9 Block Admission Applications 04 Sep 08
10 Directors Buy 310,500 Shares 12 Aug 08
11 Medicsight Interim Results For the Six Months Ended 30 June 2008 08 Aug 08
12 Brazilian State Food and Drug Administration approval 07 Aug 08
13 2007 Annual Report and Accounts 27 Jun 08
14 Presentation at Piper Jaffray Annual Europe Conference 23 Jun 08
15 New Study Shows Potential of Medicsight ColonCAD Technology to Effectively Triage Patients and Relieve Burden of Radiologist Shortage 18 Jun 08
16 Exclusive Colon CAD research collaboration with leading US CT Colonography radiologists Dr Perry Pickhardt and Dr David Kim 04 Jun 08
17 Preliminary Results for the 12 months ended 31 December 2008 02 Jun 08
18 2008 Annual Report and Accounts and notice of AGM 02 Jun 08
19 Appointment of Corporate Adviser - Appointment of NM Rothschild & Sons Limited as corporate adviser 16 May 08
20 Change of Adviser - Appointment of Nomura Code as NOMAD and broker 14 May 08
 
<< Start < Prev 1 2 Next > End >>
Page 1 of 2
Investor Relations
Search Medicsight
Key Events
feed-image
Medicsight PLC is incorporated and registered in England and Wales which is the main operating country. The company registration number is 04268510.
Registered address: Kensington Centre, 66 Hammersmith Road, W14 8UD, Tel: +44 (0)20 7605 7950 Fax: +44 (0)207 605 7951